key: cord-0856275-120hmv5b
authors: Doggett, Nathan; Chow, Chung-Wai; Mubareka, Samira
title: Characterization of experimental and clinical bioaerosol generation during potential aerosol-generating procedures
date: 2020-07-21
journal: Chest
DOI: 10.1016/j.chest.2020.07.026
sha: bd8926d9b26ef2675573288a555220937d248881
doc_id: 856275
cord_uid: 120hmv5b

Abstract Background During medical procedures with the potential to produce aerosols such as bronchoscopy, intubation or cardiopulmonary resuscitation, healthcare workers (HCWs) may be exposed to infectious bioaerosols. This is of particular concern when high consequence pathogens such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are circulating. Thus far thousands of HCWs have been infected, 14.8% of these have severe disease and several have died1. However, the determinants of aerosol generation during such procedures and their relative risk to HCWs remain poorly characterized. Research Question. We sought to characterize aerosols produced during airway intubation using an uninfected translational animal model and in human subjects undergoing elective aerosol-generating procedures. We also determined the particle size distribution of generated particles. Study Design and Methods. Aerosol generation was measured during highly controlled experimental (pig) intubations (N=16) and elective bronchoscopies in uninfected patients (N=49) using an optical particle counter (OPC). Recovery of normal respiratory flora was used as a surrogate for pathogen dispersion. Results There was a small but significant (p = 0.03) decrease in 0.3 μm particles during highly controlled pig intubations compared to baseline. The concentration of 1.0 μm and 5.0 μm aerosol particles did not significantly change though oral bacteria were collected from the air. For elective patient bronchoscopies, there was a significant decrease in the generation of larger particles (1.0 μm and 5.0 μm) compared to baseline (p < 0.01), however, 18 of 39 (46%) of patients showed increased aerosol production in 0.3 μm sized particles, 4 of whom demonstrated significant increases. Interpretation. While the total amount of aerosols produced during intubation and bronchoscopy did not increase significantly relative to pre-procedural levels, a small number of participants showed a significant increase in submicron particle emission, meriting further research to delineate determinants of fine particle production during aerosol-generating procedures.

from basic science to evidence based options for control, Hong Kong 29 30 31 32 generating procedures. We also determined the particle size distribution of generated particles. 48 Study Design and Methods. Aerosol generation was measured during highly controlled 49 experimental (pig) intubations (N=16) and elective bronchoscopies in uninfected patients (N=49) 50 using an optical particle counter (OPC). Recovery of normal respiratory flora was used as a 51 surrogate for pathogen dispersion. 52

Results. There was a small but significant (p = 0.03) decrease in 0.3 µm particles during highly 53 controlled pig intubations compared to baseline. The concentration of 1.0 µm and 5.0 µm aerosol 54 particles did not significantly change though oral bacteria were collected from the air. For 55 elective patient bronchoscopies, there was a significant decrease in the generation of larger 56 particles (1.0 µm and 5.0 µm) compared to baseline (p < 0.01), however, 18 of 39 (46%) of patients showed increased aerosol production in 0.3 μm sized particles, 4 of whom demonstrated 58 significant increases. 59

Interpretation. While the total amount of aerosols produced during intubation and 60 bronchoscopy did not increase significantly relative to pre-procedural levels, a small number of 61 participants showed a significant increase in submicron particle emission, meriting further 62 research to delineate determinants of fine particle production during aerosol-generating 63 procedures. 64 65 66

Medical procedures with the potential to produce aerosol particles include endotracheal 67 intubation 2,3 , extubation and bronchoscopy 4,5 . Bioaerosols (aerosol particles of biological origin) 68 generated during these aerosol-generating procedures (AGPs) may represent a risk to exposed 69 healthcare workers (HCWs) when patients are infected or colonized with a respiratory pathogen. 70

The importance of understanding the risks associated with AGPs was emphasized during the 71 SARS epidemic of 2003, when HCWs suffered a substantial burden of the total SARS cases 72 despite adherence to enhanced droplet and airborne precautions 2,3,6,7 . Furthermore, retrospective 73 analyses revealed evidence of potential airborne transmission of SARS during AGPs 8-10 . A 74 systematic review evaluating the risk of acquiring SARS for HCWs performing AGPs compared 75 to those providing care, but not involved in AGPs, found that endotracheal intubation was 76 associated with a significant increased risk of acquiring SARS 10 . However, there remains a 77 dearth of empiric data regarding bioaerosol production and quantification during AGPs, and 78 associated risks remain poorly characterized. The current situation with coronavirus disease-19 79 (COVID-19) underscore the importance of understanding these risks, given the implications for patient management, risk mitigation and HCW health. HCW health is of particular importance 81 due to their essential roles and risk of transmission from HCWs to other HCWs and patients. 82

Airway manipulation during bronchoscopy has been shown to trigger the cough reflex in 83 many patients, potentially producing significant aerosols, which may contain pathogenic 84 microorganisms. Recent small-scale studies have found that a significant number of aerosols 85 were produced during bronchoscopy and identified an increase in aerosol-borne respiratory 86 bacteria during the procedure compared to an empty room 11,12 . Here, our objective was to 87 measure the quantity and size of aerosols produced during highly controlled experimental and 88 clinical settings including the pig animal model and elective patient bronchoscopies respectively. 89

Methods 90

An AeroTrak® optical particle counter (OPC Model 9303; TSI Incorporated, Shore-91 view, MN, USA) was used to quantify aerosol production based on particle number and size. 92

This instrument operates on the basis of light scattering generated by individual particles as they 93 pass individually through a light cell. This OPC adheres to the ISO 21501-4 calibration 94 requirements for light scattering airborne particle counters, indicating a volumetric flow rate of ± 95 5%, a counting efficiency of (50 ±20) % at the minimum detectable particle size, (100 ±10) % 96 for particles 1.5 to 2 times larger than the minimum detectable size, and a size resolution (the 97 maximum difference in size measured by the OPC compared to selected size) of ≤15%. 98

This instrument was selected based on the portability, ease of use and minimal disruption 99 to patient care. Particles were captured and counted in three size categories, 0.3 μm, 1.0 μm, and 100 5.0 μm, representing particle size ranges with preferential deposition throughout the upper and 101 lower respiratory tract. Bioaerosols within the respirable aerosol size fraction can include fungi (0.5-30 μm), bacteria (0.3-10 μm), viruses (0.02-0.3 μm; often found in clusters or attached to 103 larger particles) and smaller cellular debris and biotoxins 13 . 104

Aerosol production in an animal model. 106

In order to optimize a protocol using an OPC for 1) the enumeration of particles from a 107 mammalian host and 2) recovery of normal respiratory flora from these particles, aerosol 108 production was measured in a highly-controlled experimental setting during pig intubations; 109 these were conducted for unrelated imaging studies. This model was used to evaluate both our 110 sampling protocol and to determine a baseline sampling method under experimental, controlled 111

conditions. The suite in which the pigs were intubated was a negative pressure room operating at 112 12 air exchanges per hour. Animals were administered atropine and ketamine and a small 113 amount of isoflurane via an anesthetic mask prior to intubation. However, the isoflurane was 114 turned off and removed prior to intubation; no mask ventilation was administered. Aerosol 115 generation measured during and immediately following intubation (10 sec post-intubation) was 116 compared to a baseline concentration of aerosols immediately before intubation (10 sec pre-117 intubation). In addition, bioaerosol content was assessed using a high-volume (300 L/min) 118

Coriolis air sampler that collects particles in a liquid medium (phosphate buffered saline), and a 119 low volume 1.0 μm polytetrafluoroethylene filter cassette sampler drawing air at 3.5 L/min. Both 120 samplers were placed within the breathing zone of research personnel performing the intubation 121 at the head of the bed and within 3 feet of the HCW performing the intubation . Samples 122 collected were plated on blood agar and colony forming units were identified using matrix 123 assisted laser desorption ionization time-of-flight mass spectrometry 14 . 124

Aerosol production during elective bronchoscopy 126

Aerosol generation was also measured during elective patient bronchoscopies. Inpatients 127 and outpatients were identified through the scheduling roster and approached by the attending 128 respirologist. Inclusion criteria were age >18 years old and capable of providing informed 129 consent. Inpatients undergoing urgent bronchoscopy in the emergency department or critical 130 care units were excluded. 131

Elective bronchoscopies were performed in endoscopy suites at two separate tertiary care 132 centers (center 1, N=25; center 2, N=24). Both procedure rooms were negative pressure 133 endoscopy suites with 12 air changes per hour. Neither of the rooms had an anteroom, however 134 all doors were closed prior to and during the procedure. 135

Particle generation during and immediately following bronchoscope removal (100 136 seconds post-procedure, or time to door opening if shorter than 100 seconds) was compared to a 137 pre-procedure baseline immediately preceding the insertion of the bronchoscope (100 seconds 138 pre-procedure), with all medical personnel present and donned in personal protective equipment 139 (PPE). This baseline was chosen over an empty room due to the observation that the presence of 140 personnel alone generated aerosols despite wearing N95 masks. This may be attributed to re-141 entrainment of settled particles and skin desquamation. Aerosols were sampled 0.75 m from the 142 patient's head at the foot of the bed at a flow rate of 2.83 L/min (Fig 1) . Timing of specific 143 procedural events including scope insertion, scope removal, coughing, suction, bronchoalveolar 144 lavage (BAL) and biopsies were recorded for later analysis of aerosol generation. 145

In addition, the presence of bacteria in the air was measured during a subset of 146 bronchoscopies using a small portable personal air sampler (3.5 L/min) consisting of a 1.0 μm 147 PTFE filter cassette worn within the breathing zone (at the collar) of research personnel to assess potential exposure to oral flora from the patient as a surrogate for potentially infectious pathogen 149 of airway origin, and the collection of oral or respiratory flora was used as an indicator of 150 potential HCW exposure during the procedure. The study was approved by the University Health 151

Network (17-5161) and Sunnybrook Research Institute Research Ethics Boards (257-2014); 152 informed consent was obtained, and the study conducted in accordance with the amended 153

Declaration of Helsinki . 154

The primary outcome for this study was enumeration of aerosol generation during 155 bronchoscopy compared to a baseline immediately before the procedure. A Wilcoxon matched-156 pairs signed rank test was used to evaluate statistical difference for the primary outcome 157 measure. The secondary outcome of this study was aerosol generation with respect to specific 158 procedural activities including bronchoscope insertion, scope removal, coughing, suctioning, 159 BAL, and biopsy. A Friedman test was used to evaluate statistical significance for the secondary 160 outcome. All statistical analyses were performed using GraphPad Prism version 8.4.2. 161 162

Aerosol production during pig intubations. 164 A total of 16 pig intubations were sampled in this study. There was no significant 165 increase in aerosol production in any size category (Fig 2) . There was a small but significant 166 decrease in 0.3 μm sized particles of -37.6 (CI -164.7 to -10.67) during intubation compared to 167 baseline (p=0.03) (Fig 2) . The air sample collection for bacteria using the Coriolis was 168 (2/39) showed increased generation compared to baseline for 1.0 and 5.0 μm sized particles, 181 respectively (Fig 3) . When analyzed as a group, no significant difference in aerosol production 182 was observed in 0.3 μm sized particles at either study site (Table 1) . Four patients demonstrated 183 a significant increase in 0.3 μm sized particles. A significant decrease in aerosol production was 184 observed for 1.0 μm sized particles at both study sites, as well as overall (p < 0.01). 185 Bronchoscopies at both sites had a significant decrease in aerosol production for 5.0 μm sized 186 particles individually (p < 0.01 and p < 0.01 respectively) and overall (p < 0.0001) (Fig 3) . 187

Importantly, considerable amount of inter-procedure variation was also observed in all size 188 categories (Fig 3) . 189

The data was further analyzed to determine aerosol generation during specific procedural 190 events including scope insertion, scope removal, coughing, suction, BAL and biopsies. Both 191 suction (p = 0.10) and BAL (p =0.11) were associated with increased aerosol production in the 192 smaller 0.3 μm sized particles, although neither reached statistical significance (Fig 5) . Bacteria 193 was recovered from the portable personal air sampler in 3 of 18 bronchoscopies. In a recent study, Lavoie et al 12 , evaluated aerosol and bioaerosol generation during 15 207 bronchoscopies using a UV-APS, and found a significant increase in particles across a range of 208 size categories. However, the baseline in this study was an empty room. The use of an empty 209 room as baseline may over-estimate the quantity of particles attributed to the procedure, when in 210 fact a proportion is due to the presence of personnel and pre-procedure activities. We used the 211 period immediately preceding the insertion of the bronchoscope as the representative baseline, 212 with personnel in the room. Incorporation of particles generated by the presence of personnel 213 allowed us to attribute changes in particle concentration to the bronchoscopy alone. 214

We did not observe a significant change in aerosol generation in the experimental setting during 215 pig intubations. This was not entirely unexpected given the degree of sedation and paralysis prior 216 to intubations. Bacteria known to be normal oral flora in human and pigs (S. mitis, non-pathogenic Neisseria sp., S. salivarius) and L. adecarboxylata is of swine origin. This suggests 218 that the sampler collected oral secretions via droplets and/or aerosols from the pig during the 219 intubation, since research personnel were masked and are unlikely to be the source of the oral 220 flora. 221

We detected an increase in fine particle production in 46% of bronchoscopies, and a 222 sizable increase in 10%, or from four participants. Unfortunately, this study is insufficiently 223 powered to identify determinants of increased fine particle production and definitively exclude 224 the possibility that this observation is due to random variation; this could be addressed through a 225 larger study and comprehensive metadata collection.

This underscores the potential risk for 226 HCW exposure in the absence of adequate ventilation and personal protection. In the setting of 227 COVID-19, this is of particular importance, highlighting the need to avoid bronchoscopy where 228 possible. 229

We noted a reduction of larger particle generation. This may be attributed to obstructions 230 such as the inserted bronchoscope, gauze used around the scope and bite block, which may have 231 obstructed the release of larger particles during some procedures, though this practice varied. 232

Alternatively, the fact that 1.0 and 5.0 µm size range particles were higher during the pre-233 procedural period may highlight a period of potentially unseen exposure risk, during which 234

HCWs may be unknowingly exposed to an increased concentration of aerosols before donning 235 PPE for the procedure, possibly as a result of particle re-entrainment. If procedures are 236 performed serially, this particle re-entrainment may expose HCWs to potentially infectious 237 bioaerosols from the previous procedure. It is also possible that the pre-procedure aerosol 238

concentrations are a result of unsettled aerosols generated by the clinical staff themselves, prior 239 to donning PPE. 240

There were several limitations to this study. Interpatient variation was observed, 241 indicating that specific host and procedural factors may be determinants of aerosol generation 242 during bronchoscopy. However, the precise quantity of increased aerosols that constitutes a 243 significant increased risk of infection to HCWs remains unclear. Although this work represents 244 one of the larger studies to quantify aerosols from patients undergoing bronchoscopy, it was not 245 designed to identify determinants of significantly greater fine aerosol production, though it does 246 provide the baseline data to design a sufficiently-powered study. More research needs to be 247 done to identify specific demographic, clinical or procedural determinants for increased fine 248 aerosol production, and to correlate the dispersion of oral flora with potential pathogens. Ideally, 249

we would establish a threshold of bioaerosol production that correlated clearly with risk to 250

HCWs, however this would depend on pathogen (infectious dose, survivability in air, virulence, 251 infectivity etc.) and host (PPE use, susceptibility, co-morbidities, etc.) factors. In short, it is very 252 difficult to determine a safe limit for bioaerosol exposure. This reinforces the need for risk 253 reduction through engineering controls and PPE. Future studies endeavoring to do so would be 254 required to determine which situations may pose a risk to HCWs. 255

The choice of an OPC was for ease of use and portability. This instrument does not 256 determine the presence of biological material in the air. Also, without knowing particle density, 257 it is not possible to determine particle mass. Light scattering is affected by particle size, shape 258 and refractive index, which is another limitation of OPCs, and a scanning mobility particle sizer 259 (SMPS) would be more precise. Unfortunately, this instrument would not be portable, 260 precluding nimble, non-disruptive sampling at multiple study sites. 261

An additional, important limitation of this study is the exclusion of less controlled, urgent 262 procedures such as intubations in the emergency department or in critical care, since these situations are perceived to bear higher risk for HCWs. This was attempted, however high 264 baseline levels of aerosols due to inconsistent mask use, HCW activities and uncontrolled 265 settings with highly variable ventilation precluded the ability to attribute changes in aerosol 266 concentration to the AGP when these measurements were attempted at our institution. We 267 appreciate that data from elective, controlled bronchoscopy will not necessarily reflect the 268 abundance or infectivity of bioaerosols generated during activities that are more likely to be 269 associated with virus transmission in the setting of COVID-19, but it does support protocol 270 development for empiric data collection for controlled intubations of patients infected with 271

Interpretation 273

We observed the a statistically significant increase in fine particle generation in a 274 minority (N=4) of patients. These data support the need for ongoing research including clinical 275 data collection to identify determinants of increased fine aerosol production and underscore the 276 importance of PPE while performing AGPs while avoiding bronchoscopy in COVID-19 277 confirmed cases. A more complete understanding of bioaerosol generation during bronchoscopy 278 will ultimately enhance risk assessment for HCW exposure to respiratory pathogens. Table 1 Take Home Point pullout. We characterized aerosols produced during aerosol-generating 378 procedures and found a small number of participants showed a significant increase in submicron 379 particle emission, meriting further research to delineate determinants of fine particle production 380 during aerosol-generating procedures. 381

Characteristics of and Important Lessons From the Coronavirus 290 Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases 291 From the Chinese Center for Disease Control and Prevention. JAMA. 2020. 292 2

Transmission of severe acute respiratory 295 syndrome during intubation and mechanical ventilation

Public Health Agency of Canada. Prevention and Control of Influenza during a Pandemic 298 for All Healthcare Settings -Pandemic Influenza: Aerosol-Generating Medical 299

Occupational tuberculous infections 302 among pulmonary physicians in training

Evidence of airborne transmission of SARS

Investigation of a nosocomial outbreak of severe 306 acute respiratory syndrome (SARS) in Toronto

Possible SARS coronavirus transmission 308 during cardiopulmonary resuscitation

A major outbreak of severe acute respiratory syndrome in 310

Evidence of airborne transmission of the severe acute 312 respiratory syndrome virus

Bacteria emitted in ambient 314 air during bronchoscopy-a risk to health care workers?

Evaluation of bioaerosol exposures during 316 hospital bronchoscopy examinations

Properties, behavior, and measurement of airborne particles

MALDI-TOF mass spectrometry: an 320 emerging technology for microbial identification and diagnosis

Quantifying the risk of respiratory infection in 323 healthcare workers performing high-risk procedures

Aerosol-Generating Procedures 326 and Risk of Transmission of Acute Respiratory Infections: A Systematic Review